Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In order to clarify the biological activities of (-)-oxetanocin G, and (-)-oxetanocin A and its carbocyclic analogue, (-)-carboxetanocin G, the inhibitory effects of triphosphate derivatives of these compounds (
OXT
-GTP,
OXT
-ATP, and C-
OXT
-GTP) on eukaryotic and viral DNA polymerases were examined.
DNA polymerase alpha
purified from calf thymus was weakly inhibited by
OXT
-GTP and
OXT
-ATP but strongly by C-
OXT
-GTP, the Ki value being 0.22 microM. On the other hand, rat DNA polymerase beta was not affected by these analogues. DNA polymerase gamma purified from bovine testes was very weakly inhibited by
OXT
-GTP and
OXT
-ATP, but not by C-
OXT
-GTP. DNA polymerase from herpes simplex virus type-II (HSV-II) was strongly inhibited by all three analogues, the Ki values ranging from 0.5 to 1.0 microM. Human immunodeficiency virus-encoded reverse transcriptase (HIV RT) was also strongly inhibited by these three analogues, the Ki value of C-
OXT
-GTP being slightly smaller than that of
OXT
-GTP or
OXT
-ATP. Analysis of products synthesized on singly primed M13 single-stranded DNA by
DNA polymerase alpha
, HSV-II DNA polymerase or HIV RT in the presence of the analogues revealed that
OXT
-GTP and C-
OXT
-GTP were incorporated into DNA and caused chain termination mainly at sites one or two nucleotides beyond the cytosine bases on the template.
...
PMID:Inhibitory effects of triphosphate derivatives of oxetanocin G and related compounds on eukaryotic and viral DNA polymerases and human immunodeficiency virus reverse transcriptase. 138 92
Oxetanocin G(9-(2-deoxy-2-hydroxymethyl-beta-D-erythro-oxetanosyl)guanine,
OXT
-G) is a potent and selective agent against human cytomegalovirus (HCMV). In this study we synthesized the triphosphate form of
OXT
-G,
OXT
-GTP, and examined its effect on the activities of HCMV DNA polymerase, herpes simplex type 2 (HSV-2) DNA polymerase and human
DNA polymerase alpha
.
OXT
-GTP was found to inhibit all these polymerases in a competitive manner with respect to dGTP. The Km for dGTP and the Ki for
OXT
-GTP of HCMV DNA polymerase were 0.86 and 0.53 mu M, respectively, while the corresponding values of
DNA polymerase alpha
were 2.2 and 3.6 mu M, respectively. HPLC analysis using [3H]
OXT
-G also revealed that
OXT
-G was converted to its triphosphate form 7- to 8-fold more efficiently in HCMV-infected cells than in uninfected cells. The results suggest that both the preferential phosphorylation of
OXT
-G in HCMV-infected cells and the preferential inhibition of HCMV DNA polymerase by
OXT
-GTP may contribute towards the selective activity of
OXT
-G against HCMV replication.
...
PMID:Mechanism of inhibition of human cytomegalovirus replication by oxetanocin G. 185 Oct 5
Telomerase, responsible for telomere synthesis, is expressed in approximately 90% of human tumor cells but seldom in normal somatic cells. In this study, inhibition by carbocyclic oxetanocin G triphosphate (C.
OXT
-GTP) and its analogues was investigated in order to clarify the susceptibility of telomerase to various nucleotide analogues. C.
OXT
-GTP competitively inhibited telomerase activity with respect to dGTP However, C.
OXT
-GTP had a potent inhibitory effect on
DNA polymerase alpha
. It was examined whether the nucleoside (C.
OXT
-G) was able to alter telomere length in cultured human HL60 cells. Contrary to expectation, long-term treatment with 10 microM C.
OXT
-G was found to cause telomere lengthening.
...
PMID:Synthetic nucleosides and nucleotides. 43. Inhibition of vertebrate telomerases by carbocyclic oxetanocin g (C.OXT-G) triphosphate analogues and influence of C.OXT-G treatment on telomere length in human HL60 cells. 1683 44